-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Organogenesis Holdings, Maintains $9 Price Target

Benzinga·12/26/2025 11:02:25
語音播報
BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $9 price target.